CN109414409A - 药物组合物 - Google Patents

药物组合物 Download PDF

Info

Publication number
CN109414409A
CN109414409A CN201780041970.8A CN201780041970A CN109414409A CN 109414409 A CN109414409 A CN 109414409A CN 201780041970 A CN201780041970 A CN 201780041970A CN 109414409 A CN109414409 A CN 109414409A
Authority
CN
China
Prior art keywords
lotion
pharmaceutically acceptable
cellulose
oil
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780041970.8A
Other languages
English (en)
Chinese (zh)
Inventor
C.冯科斯万特
R.博尔德斯
S.P.M.耶尔姆约纳松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN109414409A publication Critical patent/CN109414409A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
CN201780041970.8A 2016-07-08 2017-07-06 药物组合物 Pending CN109414409A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1611920.8 2016-07-08
GBGB1611920.8A GB201611920D0 (en) 2016-07-08 2016-07-08 Pharmaceutical compositions
PCT/EP2017/066983 WO2018015175A1 (en) 2016-07-08 2017-07-06 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CN109414409A true CN109414409A (zh) 2019-03-01

Family

ID=56890842

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780041970.8A Pending CN109414409A (zh) 2016-07-08 2017-07-06 药物组合物

Country Status (20)

Country Link
US (1) US20200254046A1 (enExample)
EP (1) EP3481377A1 (enExample)
JP (1) JP2019520393A (enExample)
KR (1) KR20190026816A (enExample)
CN (1) CN109414409A (enExample)
AU (1) AU2017298873B2 (enExample)
BR (1) BR112019000240A2 (enExample)
CA (1) CA3029331A1 (enExample)
CL (1) CL2019000042A1 (enExample)
CO (1) CO2019000083A2 (enExample)
CR (1) CR20190007A (enExample)
DO (1) DOP2019000002A (enExample)
EA (1) EA201990162A1 (enExample)
GB (1) GB201611920D0 (enExample)
IL (1) IL263999A (enExample)
MX (1) MX2019000255A (enExample)
PE (1) PE20190321A1 (enExample)
PH (1) PH12019500024A1 (enExample)
SG (1) SG11201811223YA (enExample)
WO (1) WO2018015175A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022071463A1 (enExample) * 2020-10-02 2022-04-07
WO2022071461A1 (ja) * 2020-10-02 2022-04-07 住友精化株式会社 粘性組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040044050A1 (en) * 2002-06-17 2004-03-04 Goodman Daniel W. Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
CN101686700A (zh) * 2007-05-30 2010-03-31 雀巢产品技术援助有限公司 水包油乳剂及其用于延迟释放活性成分的用途
CN102421422A (zh) * 2009-03-09 2012-04-18 普罗诺瓦生物医药挪威公司 含有脂肪酸油混合物和表面活性剂的组合物及其方法和用途
CN102512664A (zh) * 2010-12-31 2012-06-27 舒泰神（北京）生物制药股份有限公司 一种神经生长因子组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2465988A (en) * 2008-12-03 2010-06-09 Omegatri As Powder or tablet containing unsaturated fatty acid and water insoluble carbohydrate
JP6399655B2 (ja) 2012-01-06 2018-10-03 オムセラ・ファーマシューティカルズ・インコーポレイテッド 遊離酸型のオメガ−３多価不飽和脂肪酸のｄｐａ濃縮組成物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040044050A1 (en) * 2002-06-17 2004-03-04 Goodman Daniel W. Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
CN101686700A (zh) * 2007-05-30 2010-03-31 雀巢产品技术援助有限公司 水包油乳剂及其用于延迟释放活性成分的用途
CN102421422A (zh) * 2009-03-09 2012-04-18 普罗诺瓦生物医药挪威公司 含有脂肪酸油混合物和表面活性剂的组合物及其方法和用途
US20120225945A1 (en) * 2009-03-09 2012-09-06 Svein Olaf Hustvedt Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
CN102512664A (zh) * 2010-12-31 2012-06-27 舒泰神（北京）生物制药股份有限公司 一种神经生长因子组合物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FUKUZUMI, HAYAKA: "Dispersion stability and aggregation behavior of TEMPO-oxidized cellulose nanofibrils in water as a function of salt addition", 《CELLULOSE》 *
HU, ZHEN: "Dried and Redispersible Cellulose Nanocrystal Pickering Emulsions", 《ACS MACRO LETTERS》 *
L. SANGUANSRI: "Microencapsulated Fish Oil Powder Formulation with Improved Resistance to Oil Leakage During Powder Compression", 《EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES》 *

Also Published As

Publication number Publication date
AU2017298873B2 (en) 2020-04-30
DOP2019000002A (es) 2019-03-31
SG11201811223YA (en) 2019-01-30
CL2019000042A1 (es) 2019-04-12
EP3481377A1 (en) 2019-05-15
KR20190026816A (ko) 2019-03-13
PH12019500024A1 (en) 2019-11-04
JP2019520393A (ja) 2019-07-18
PE20190321A1 (es) 2019-03-04
US20200254046A1 (en) 2020-08-13
CA3029331A1 (en) 2018-01-25
AU2017298873A1 (en) 2019-02-14
EA201990162A1 (ru) 2019-06-28
MX2019000255A (es) 2019-05-27
GB201611920D0 (en) 2016-08-24
WO2018015175A1 (en) 2018-01-25
IL263999A (en) 2019-01-31
WO2018015175A9 (en) 2018-03-29
BR112019000240A2 (pt) 2019-04-16
CO2019000083A2 (es) 2019-01-18
CR20190007A (es) 2019-03-05

Similar Documents

Publication Publication Date Title
Li et al. Self-nanoemulsifying drug-delivery system and solidified self-nanoemulsifying drug-delivery system
Carvalho et al. Microencapsulation by spray drying of emulsified green coffee oil with two-layered membranes
AU2011280348B2 (en) Method for preparing microspheres and microspheres produced thereby
DE10026698A1 (de) Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US10166187B2 (en) Curcumin solid lipid particles and methods for their preparation and use
JP7671693B2 (ja) 非クルクミノイドの水溶性粒子とクルクミノイドの水溶性粒子から構成される製剤
Chambin et al. Influence of cryogenic grinding on properties of a self-emulsifying formulation
Lacatusu et al. Lipid nanocarriers based on natural compounds: An evolving role in plant extract delivery
Raffin et al. Natural lipid nanoparticles containing nimesulide: synthesis, characterization and in vivo antiedematogenic and antinociceptive activities
JP4028642B2 (ja) 乳化粉末の製造方法
JPH0753835A (ja) 有効成分を含有するコアポリマー、コアシェルポリマーおよびそれらの製造法
CN109414409A (zh) 药物组合物
WO2002083099A1 (de) Pharmazeutische formulierungen enthaltend entzündungshemmende wirkstoffe und deren verwendung
Xia et al. Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel–cholesterol complex
Chukwuma Self-Emulsifying Formulations: A Pharmaceutical Review.
Zin et al. Systematic development by the design-of-experiment approach and physicochemical evaluations of the optimized self-microemulsifying astaxanthin delivery system
JP4282730B2 (ja) 乳化粉末の製造方法
CA2274516C (en) Process for the preparation of emulsified powders
Pohlen et al. Relative bioavailability enhancement of simvastatin via dry emulsion systems: Comparison of spray drying and fluid bed layering technology
Karakucuk et al. Ritonavir nanosuspensions prepared by microfluidization with enhanced solubility and desirable immunological properties
Aboueisha et al. Effect of ethyl cellulose content on release profile and pharmacodynamics of fenoprofen microparticles
Chengaiah et al. Self emulsifying drug delivery system: a novel approach for drug delivery
Nguyen Extrusion-spheronization of pharmaceutical products: system for the delivery of active ingredients which are poorly soluble by oral route
Malik et al. Gamma oryzanol loaded microspheres with improved bioavailability
Azhar et al. Strategies for the development of Mitragyna speciosa (Kratom) leaves extract loaded with solid lipid nanoparticles

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190301

WD01 Invention patent application deemed withdrawn after publication